DJIA 16,498.03 98.36 0.60%
NASDAQ 4,385.19 69.12 1.60%
S&P 500 1,927.18 23.17 1.22%
market minute promo

Chimerix (NASDAQ: CMRX)

30.51 -0.15 (-0.49%)

Quote as of

company name or ticker

Recent Quotes

CMRX $30.51 -0.49%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $30.18
Previous Close $30.66
Daily Range $29.80 - $30.61
52-Week Range $12.96 - $36.75
Market Cap $1.1B
P/E Ratio 438.00
Dividend (Yield) $0.00 (0.0%)
Volume 289,689
Average Daily Volume 1,887,379
Current FY EPS -$1.68



Chimerix (CMRX) Description

Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157. Website:

News & Commentary

Why Chimerix, Inc. Shares Took Off

Chimerix shares rally following the close of its share offering. Find out what shareholders should have their eyes on instead.

Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback

Chimerix (CMRX) Showing Signs Of Perilous Reversal Today

Chimerix (CMRX) Hits New Lifetime High Today

Benzinga's Top #PreMarket Gainers

Chimerix's (CMRX) CEO Michelle Berrey Hosts R&D Update (Transcript)

Trade-Ideas: Chimerix (CMRX) Is Today's Post-Market Leader Stock

Could Sinovac Biotech Be The Next Ebola Play?

Ebola-Related Stocks Continue Higher

Chimerix Says Will Offer R&D Update on Webcast on Oct. 15th at 4:30 p.m. EDT

Ebola Stocks: A Real Portfolio Killer

See More CMRX News...